期刊文献+

细胞色素P4502D6基因多态性和药物相互作用 被引量:18

Genetic polymorghism of CYP2D6 and drug interactions
下载PDF
导出
摘要 细胞色素P4502D6(CYP2D6)是一种重要的P450系氧化代谢酶,参与多种重要药物的代谢。CYP2D6具有基因多态性,对药物的代谢呈现明显的个体差异。而且CYP2D6能被多种药物竞争性抑制和诱导,药物联用时易产生相互作用。本文从CYP2D6的基因多态性与代谢表型、底物竞争作用、代谢酶的诱导和抑制等方面,探讨CYP2D6基因多态性与药物相互作用的关系。 As one of major cytochrome P450s, CYP2D6 is responsible for many important drugs' metabolism. The genetic polymorphism of CYP2D6 is the basis of significant individual variability in the metabolism of drugs. Meanwhile, many drugs can influence the activity of CYP2D6 by competitive inhibition or induction, which is easy to eause interaction in eoadministration. So we will investigate the relations of genetic polymorphism of CYP2D6 to drug interactions from such aspects as phenotype, competitive inhibition of substrates, induction or inhibition of CYP2D6.
作者 李芹 王睿
出处 《中国临床药理学与治疗学》 CAS CSCD 2006年第4期369-374,共6页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 国家863计划资助项目(№2004AA2Z3765)
关键词 CYP2D6 基因多态性 药物相互作用 抑制 诱导 CYP2D6 genetic polymorphism drug interactions inhibition induction
  • 相关文献

参考文献32

  • 1孙忠实,朱珠.药物代谢性相互作用研究进展[J].医药世界,2004(8):60-61. 被引量:5
  • 2付良青,吴德政.细胞色素P4502D6的研究进展[J].中国临床药理学杂志,2000,16(6):453-457. 被引量:10
  • 3http://www.imm.ki.se/CYPallele/cyp2d6.htm
  • 4Vandel P,Haffen E,Nezelof S.Clomipramine,fluoxetine and CYP2D6 metabolic capacity in depressed patients[J].Hum Psychopharmacol,2004;19:293-8
  • 5Eap CB,Sirot EJ,Baumann P.Therapeutic monitoring of antidepressants in the era of pharmacogenetics studies[J].Ther Drug Monit,2004;26:152-5
  • 6Brosen K.Some aspects of genetic polymorphism in the biotransformation of antidepressants[J].Therapie,2004;59:5-12
  • 7Eap CB,Bondolfi G,Zullino D,Savary-Cosendai L,Powell-Golay K,Kosel M,et al.Concentrations of the enantiomers of fluoxetine and norfluoxetine after multiple doses of fluoxetine in cytochrome P4502D6 poor and extensive metabolizers[J].J Clin Psychopharmacol,2001;21:330-4
  • 8Vandel S,Bertschy G,Baumann P,Bouquet S,Bonin B,Francois T,et al.Fluvoxamine and fluoxetine:interaction studies with amitriptyline,clomipramine and neuroleptics in phenotyped patients[J].Pharmacol Res,1995;31:347-53
  • 9Yoon YR,Cha IJ,Shon JH,Kim KA,Cha YN,Jang IJ,et al.Relationship of paroxetine disposition to metoprolol metabolic ratio and CYP2D6·10 genotype of Korean subjects[J].Clin Pharmacol Ther,2000; 67:567-76
  • 10Kari L,Steven DB,Harry B,Juha R,Jutta H,Harry S,et al.Effect of the novel anxiolytic drug deramciclane on cytochrome P450 2D6 activity as measured by desipramine pharmacokinetics[J].Eur J Clin Pharmacol,2004;59:893-8

二级参考文献15

  • 1陶恩祥.细胞色素氧化酶P450ⅡD6多态性及其分子生物学进展[J].国外医学(遗传学分册),1996,19(4):180-182. 被引量:3
  • 2梁民琦,中国临床药理学杂志,1992年,8卷,19页
  • 3王宏,上海医科大学学报,1990年,17卷,269页
  • 4Chan G L Y,Pharm Res,1988年,5卷,增10期,153页
  • 5Tsing Chiungy,Clin Pharmacolr,1996年,60卷,177页
  • 6Lee E J,Br J Clin Pharmacol,1994年,37卷,605页
  • 7Lee E J D,Br J Clin Pharmacol,1994年,37卷,605页
  • 8Johansson I,Mol Pharmacol,1994年,46卷,452页
  • 9Wang S L,Clin Pharmacolr,1993年,53卷,410页
  • 10Chen Z R,Br J Pharmacol,1991年,31卷,381页

共引文献24

同被引文献180

引证文献18

二级引证文献136

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部